Amarin Corporation plc, each representing one Ordinary Share (AMRN)
Amarin Corporation plc, each representing one Ordinary Share (AMRN)
$21.07 USD
Updated Jul 17 4:00pm
Add AMRN to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 213 in Medical - Pharmaceuticals
See all “A” rated Strong Buy stocks
AMRN News Stream
| Event/Time | News Detail | Start | End | Change | |||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Top Stories View All
Is Greenlane Holdings (GNLN) slipping under the radar for most cannabis investors?
The Expansion Continues for Aurora Cannabis (ACB)
Hexo Corp. (HEXO) began trading on the NYSE today, here’s what it means for the stock
Best & Worst Performing Stock Industries for July 16, 2019
Best & Worst Performing Small Cap Stocks for July 16, 2019
View All Top StoriesAmarin Corporation plc, each representing one Ordinary Share (AMRN) Company Bio
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company was founded in 1989 and is based in Dublin, Ireland.
AMRN Stock Chart More Charts
AMRN Price/Volume Stats
| Current price | $21.07 |
| Prev. close | $21.74 |
| Day low | $20.92 |
| Day high | $21.71 |
| 50-day MA | $18.91 |
| 200-day MA | $18.41 |
| 52-week high | $23.91 |
| 52-week low | $2.35 |
| Volume | 7,399,796 |
| Avg. volume | 7,586,658 |
| Dividend yield | N/A |
| Market Cap | 6.97B |
AMRN Returns
| 1-mo | 12.31% |
| 3-mo | 16.67% |
| 6-mo | 22.29% |
| 1-year | 610.62% |
| 3-year | 812.12% |
| 5-year | 1,295.36% |
| YTD | 54.81% |
| 2018 | 239.40% |
| 2017 | 30.19% |
| 2016 | 62.96% |
| 2015 | 92.86% |
| 2014 | -50.25% |
Loading social stream, please wait...